George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,711.00
Bid: 1,711.00
Ask: 1,711.20
Change: 5.80 (0.34%)
Spread: 0.20 (0.012%)
Open: 1,701.60
High: 1,711.60
Low: 1,699.40
Prev. Close: 1,705.20
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Vouchers, Grocers, Boohoo

Sun, 05th Jul 2020 15:59

(Sharecast News) - Radical plans to give all adults £500 and children £250 in vouchers to spend in sectors of the economy worst hit by the Covid-19 crisis are being considered by the Treasury. The proposals, drawn up by the Resolution Foundation think tank, which has had recent talks with the Treasury about its ideas, are aimed at kickstarting economic recovery by triggering a highly targeted surge in spending. Under the plans the vouchers could only be spent in certain sectors, such as hospitality and "face to face" retail, as opposed to online. - Guardian

Britain's grocers are gearing up for a massive price war amidst fears unemployment could rise above four million. More than 14,000 jobs were lost this week as a coronavirus jobs bloodbath hit the economy. The jobs cull has left supermarket bosses scrambling to show they are competitive on price as household budgets are squeezed due to the crisis. They are worried that the German discounters Aldi and Lidl will repeat the sort of market-share gains made after the 2008 financial crash. - Mail on Sunday

Workers in Leicester making clothes destined for the fashion giant Boohoo are being paid as little as £3.50 an hour, an undercover Sunday Times investigation has found. [...] The undercover reporter spent two days working in the factory where he was told to expect £3.50 an hour, despite the minimum wage in Britain for those aged 25 and over being £8.72. He obtained covert video footage of himself packing garments made in the factory under the label of Nasty Gal, which is owned by the fast-fashion brand Boohoo whose boss, Mahmud Kamani, is set to scoop a £50m bonus. - Sunday Times

Employers planning mass redundancies of furloughed workers face restrictions that may force them to pay back months of wages to the taxpayer. The Treasury has panicked some businesses by rewording the purpose of the Coronavirus Job Retention Scheme to say it is "integral" that its money is "used by the employer to continue the employment of employees". The change, unveiled last week, has meanwhile sparked hopes among 
 campaigners that employers will think twice before laying off swathes of Britain's 9.3 million furloughed workforce. - Sunday Telegraph

Glaxo Smith Kline and Sanofi are close to agreeing a £500m deal to supply the British government with 60 million doses of their coronavirus vaccine. The business department is understood to be taking an option to buy the vaccine from the pharmaceuticals giants should it work in human trials, which are due to begin in September. The deal for an as yet unproven vaccine underlines ministers' desperation to secure a supply as countries scramble to buy up possible Covid-19 treatments. - Sunday Times

Rolls-Royce is preparing to close its final salary pension scheme four years early to conserve cash as grounded aircraft pile pressure on its finances. The jet engine maker is seeking to end accrual of future benefits now, rather than in 2024. If Rolls gets the go-ahead from pension members and trustees following a consultation, it is likely to save a total of about £500m in contributions. Under the current arrangements, in the last financial year Rolls made total cash contributions to the pension scheme of more than £150m. - Sunday Telegraph

Bank of England governor Andrew Bailey has written to lenders warning them of the challenges negative interest rates would bring. Bailey, who succeeded Mark Carney as the virus crisis was taking hold in March, said that adapting to an unprecedented move into negative territory, where the Bank would charge commercial lenders to store reserves, would be "a significant operational undertaking for firms". He noted that many would need 12 months to change computer systems, update financial contracts designed for a world of positive interest rates and work out how to communicate with clients. - Sunday Times

The Panelbase survey also shows a commanding lead for the SNP heading into next year's Holyrood elections, with a resounding victory for Nicola Sturgeon likely to heighten calls for a second referendum on independence. Support for Scottish independence stands at 54% according to Panelbase poll for the Sunday Times, with 46% support for the union. It is the second survey in recent weeks to show this level of support among Scots for leaving the UK. - The Scotsman
More News
19 Mar 2024 09:21

LONDON BROKER RATINGS: Investec cuts ConvaTec; RBC raises Vistry

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
18 Mar 2024 12:00

GSK unveils promising results from endometrial cancer trial

(Sharecast News) - GSK unveiled promising outcomes from a phase three trial of 'Jemperli', or dostarlimab, in treating primary advanced or recurrent endometrial cancer on Monday.

Read more
18 Mar 2024 08:47

TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon

(Alliance News) - Haleon PLC on Monday said Pfizer Inc plans to sell around GBP2 billion in Haleon shares, some of which will be bought back by Haleon.

Read more
18 Mar 2024 08:47

GSK says Jemperli combination gets good results for endometrial cancer

(Alliance News) - GSK PLC on Monday said a test of its Jemperli drug in combination with chemotherapy has shown it reduced the risk of death in patients with endometrial cancer by nearly a third.

Read more
7 Mar 2024 09:38

GSK observes positive data in Blenrep trial for blood cancer treatment

(Alliance News) - GSK PLC on Thursday announced positive results for Blenrep for the treatment of multiple myeloma.

Read more
7 Mar 2024 07:21

GSK reports more encouraging trial results for Blenrep

(Sharecast News) - GSK unveiled encouraging results from its 'DREAMM-8' phase three trial on Thursday, comparing the efficacy of 'Blenrep', or belantamab mafodotin, in combination with pomalidomide plus dexamethasone, or PomDex, against the standard treatment of bortezomib plus PomDex in relapsed or refractory multiple myeloma patients.

Read more
5 Mar 2024 11:03

GSK says ViiV's cabotegravir study supports longer HIV dose interval

(Alliance News) - GSK PLC on Tuesday celebrated study results from ViiV Healthcare Ltd, that showed an investigational formulation of cabotegravir can be dosed at four-month intervals.

Read more
5 Mar 2024 07:26

GSK's ViiV upbeat on ultra-long-acting HIV treatment study

(Sharecast News) - GSK announced on Tuesday that its specialist GIV joint venture with Pfizer and Shionogi, ViiV Healthcare, had reported encouraging results from its phase one clinical trial of an investigational formulation of cabotegravir, termed cabotegravir ultra long-acting (CAB-ULA).

Read more
29 Feb 2024 09:44

TOP NEWS: GSK avoids "protracted litigation" with Zantac settlement

(Alliance News) - GSK PLC on Thursday emphasised its commitment to science, as it reached another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
29 Feb 2024 07:22

GSK reaches settlement in another Zantac case

(Sharecast News) - GSK announced a confidential settlement with Boyd/Steenvoord, effectively resolving a case filed in California state court over its discontinued heartburn drug Zantac.

Read more
26 Feb 2024 08:25

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

(Alliance News) - GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Read more
26 Feb 2024 07:22

GSK reports positive results from gonorrhoea treatment trial

(Sharecast News) - GSK announced encouraging headline outcomes from its trial of gepotidacin, an oral antibiotic aiming to address uncomplicated urogenital gonorrhoea in adolescents and adults, on Monday.

Read more
21 Feb 2024 09:47

GSK reports encouraging results for ViiV's Cabenuva HIV treatment

(Alliance News) - GSK PLC on Wednesday said that its majority-owned company ViiV Healthcare had received positive interim data from ongoing trials of its injectable HIV treatment.

Read more
21 Feb 2024 07:22

GSK's ViiV sees success in latest HIV treatment trial

(Sharecast News) - GSK's specialist HIV unit ViiV Healthcare, which it owns in partnership with Pfizer and Shionogi, unveiled promising findings from the 'LATITUDE' phase three trial of its long-acting injectable HIV treatment Cabenuva on Wednesday.

Read more
20 Feb 2024 15:10

PRESS: AJ Bell founder to join Applied Nutrition ahead of IPO - Sky

(Alliance News) - Supplements maker Applied Nutrition, plotting a London stock market float, is to add AJ Bell PLC founder Andy Bell as its chair, Sky News reported on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.